Innovation Pharmaceuticals Reports p53 Drug Candidate Therapeutic Potential Further Supported by Academic Research in Leukemias and in Combination with Cancer Immunotherapies

NEXT STORY
Veritas Farms Harvests Exclusive Relationship with Bendcare’s Oasis Health to Create Physician Formulated Sunrise and Eclipse Product Line Extension Distributed by AARA, the Largest Rheumatology Group in the U.S.
PREV STORY
Chiesi USA Promotes Medical Affairs Head to Support Continued Corporate Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pluristem Treated First Three COVID-19 Patients in Israel under Compassionate Use

author_avatar
NASDAQ Market News

Quipt Announces Strategic Acquisition of Biomedical Services Company in the Southeastern United States

author_avatar
NASDAQ Market News

Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study

Target Exceeded with More than 160 Patients Enrolled Top-Line Data on Track for 3Q17 ...

author_avatar
NASDAQ Market News